[Cancer risk in pesticide exposed agricultural workers (author's transl)]

Archiv Fur Geschwulstforschung
|January 1, 1981
PubMed

Insights

Pesticide exposure in agricultural technicians was linked to a doubled risk of bronchial carcinoma. Certain pesticides like arsenic compounds and DDT may play a role in cancer development.

Area of Science:

  • Occupational Health
  • Toxicology
  • Epidemiology

Context:

  • A cohort of 1791 agricultural technicians exposed to pesticides in the German Democratic Republic (GDR) was studied.
  • Data collection spanned all GDR regions except Berlin.

Purpose:

  • To assess the frequency of malignant neoplasms in pesticide-exposed agricultural technicians.
  • To investigate potential links between specific pesticide exposures and cancer incidence.

Summary:

  • 169 malignant neoplasms were diagnosed, with bronchial carcinoma occurring twice as often as expected in the exposed group.
  • Skin carcinoma incidence was 1.2 times higher than expected; other sites showed no significant increase.
  • Bronchial carcinoma cases had an average exposure of 13.6 years and a latency period of 17.5 years.
  • Arsenic compounds, DDT, HCH, and phenoxy acids are suspected etiological agents, particularly for bronchial carcinoma, given similar smoking habits in the general population.

Impact:

  • Suggests an etiological role for pesticide exposure in bronchial carcinoma development.
  • Highlights specific chemical agents (arsenic, DDT, HCH, phenoxy acids) as high-concern substances.
  • Informs occupational health strategies and regulatory measures for pesticide use.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...